Abstract
BackgroundTumor-antigen specific CD4+ T cells are crucial for the efficacy of antibodies that block immune checkpoint proteins in mouse tumor models, but their activities in human tumor immunity are less...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have